TickerSpark Feed

aspe

Everything tagged "aspe" across the TickerSpark archives.

Aspen Neuroscience IPO Preview: Parkinson’s Cell Therapy Meets Execution Risk

Aspen Neuroscience is expected to list on Nasdaq under the symbol ASPE on 2026-10-30, but the price range was not disclosed before pricing. The company is a clinical-stage Parkinson’s disease biotech, so the bull case is a large unmet-need market and the bear case is heavy clinical and regulatory risk.

Oct 27, 2026·5 MIN

IPO NASDAQ

On-Demand Research

Need research on a stock not covered here?

Generate AI research on any ticker — grades, price targets, and full analysis in minutes.

Open the Generator

For Active Investors

Stock research for every investor

Reports on any stock
Daily market intelligence
AI analyst in your pocket
Portfolio analysis tools

Get Full Access →

Cancel anytime

Today's Top MoverFDXF

▲14.91%

FedEx Freight Holding Company, Inc. · $126.04

Aspen Neuroscience IPO Preview: Parkinson’s Cell Therapy Meets Execution Risk

Need research on a stock not covered here?

A new stock idea, every evening.

Stock research for every investor